Differential c-Myc responsiveness to B cell receptor ligation in B cell-negative selection

Journal of Immunology

Volumn 171, Issue 5, 2003, Pages 2446-2452

  Leider, Nira ^a   Melamed, Doron ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW CULTURE; CELL COMPARTMENTALIZATION; CELL MATURATION; CONTROLLED STUDY; GENE REARRANGEMENT; LYMPHOCYTE TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE C MYC; TRANSGENIC MOUSE;

EID: 0041427918     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.5.2446     Document Type: Article

References (52)

1. Rajewsky, K. 1996. Clonal selection and learning in the antibody system. Nature 381:751.
2. Niiro, H., and E. A. Clark. 2002. Regulation of B-cell fate by antigen-receptor signals. Nat. Rev. Immunol. 2:945.
3. Shaffer, A. L., A. Rosenwald, and L. M. Staudt. 2002. Lymphoid malignancies: the dark side of B-cell differentiation. Nat. Rev. Immunol. 2:920.
4. Cole, M. D. 1986. The myc oncogene: its role in transformation and differentiation. Annu. Rev. Genet. 20:361.
5. Prendergast, G. C. 1999. Mechanisms of apoptosis by c-Myc. Oncogene 18:2967.
6. Thompson, C. B., E. H. Humphries, L. M. Carlson, C. L. Chen, and P. E. Neiman. 1987. The effect of alterations in myc gene expression on B cell development in the bursa of Fabricius. Cell 51:371.
7. Davis, A. C., M. Wims, G. D. Spotts, S. R. Hann, and A. Bradley. 1993. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7:671.
8. Harris, A. W., C. A. Pinkert, M. Crawford, W. Y. Langdon, R. L. Brinster, and J. M. Adams. 1988. The E μ-myc transgenic mouse: a model for high-incidence spontaneous lymphoma and leukemia of early B cells. J. Exp. Med. 167:353.
9. Langdon, W. Y., A. W. Harris, S. Cory, and J. M. Adams. 1986. The c-myc oncogene perturbs B lymphocyte development in E-μ-myc transgenic mice. Cell 47:11.
10. Sonenshein, G. E. 1997. Down-modulation of c-Myc expression induces apoptosis of B lymphocyte models of tolerance via clonal deletion. J. Immunol. 158:1994.
11. Fischer, G., S. C. Kent, L. Joseph, D. R. Green, and D. W. Scott. 1994. Lymphoma models for B cell activation and tolerance. X. Anti-μ-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc. J. Exp. Med. 179:221.
12. McCormack, J. E., V. H. Pepe, R. B. Kent, M. Dean, A. Marshak-Rothstein, and G. E. Sonenshein. 1984. Specific regulation of c-myc oncogene expression in a murine B-cell lymphoma. Proc. Natl. Acad. Sci. USA 81:5546.
13. Wu, M., M. Arsura, R. E. Bellas, M. J. FitzGerald, H. Lee, S. L. Schauer, D. H. Sherr, and G. E. Sonenshein. 1996. Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells. Mol. Cell. Biol. 16:5015.
14. Amati, B., T. D. Littlewood, G. I. Evan, and H. Land. 1993. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J. 12:5083.
15. Qi, C. F., A. Martensson, M. Mattioli, R. Dalla-Favera, V. V. Lobanenkov, and H. C. Morse III. 2003. CTCF functions as a critical regulator of cell-cycle arrest and death after ligation of the B cell receptor on immature B cells. Proc. Natl. Acad. Sci. USA 100:633.
16. Sater, R. A., P. C. Sandel, and J. G. Monroe. 1998. B cell receptor-induced apoptosis in primary transitional murine B cells: signaling requirements and modulation by T cell help. Int. Immunol. 10:1673.
17. 1 phase of the cell cycle in response to antigen receptor signaling. J. Immunol. 156:4562.
18. Norvell, A., L. Mandik, and J. G. Monroe. 1995. Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis. J. Immunol. 154:4404.
19. Scott, D. W., M. Lamers, G. Kohler, C. L. Sidman, B. Maddox, and R. Carsetti. 1996. Role of c-myc and CD45 in spontaneous and anti-receptor-induced apoptosis in adult murine B cells., Int. Immunol. 8:1375.
20. Parry, S. L., M. J. Holman, J. Hasbold, and G. G. Klaus. 1994. Plastic-immobilized anti-μ or anti-δ antibodies induce apoptosis in mature murine B lymphocytes. Eur. J. Immunol. 24:974.
21. Hueber, A. O., M. Zornig, D. Lyon, T. Suda, S. Nagata, and G. I. Evan. 1997. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278:1305.
22. Brunner, T., S. Kasibhatla, M. J. Pinkoski, C. Frutschi, N. J. Yoo, F. Echeverri, A. Mahboubi, and D. R. Green. 2000. Expression of Fas ligand in activated T cells is regulated by c-Myc. J. Biol. Chem. 275:9767.
23. Seagal, J., and D. Melamed. 2003. Selection events in directing B cell development. Histol. Histopathol. 18:519.
24. Nemazee, D. 2000. Receptor selection in B and T lymphocytes. Annu. Rev. Immunol. 18:19.
25. Melamed, D., R. J. Benschop, J. C. Cambier, and D. Nemazee. 1998. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell 92:173.
26. Sandel, P. C., and J. G. Monroe. 1999. Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter. Immunity 10:289.
27. Yachimovich, N., G. Mostoslavsky, Y. Yarkoni, I. Verbovetski, and D. Eilat. 2002. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status. Eur. J. Immunol. 32:1164.
28. Glynne, R. J., G. Ghandour, and C. C. Goodnow. 2000. Genomic-scale gene expression analysis of lymphocyte growth, tolerance and malignancy. Curr. Opin. Immunol. 12:210.
29. Rusell, D. M., Z. Dembic, G. Morahan, J. F. Miller, K. Burki, and D. Nemazee. 1991. Peripheral deletion of self-reactive B cells. Nature 354:308.
30. Rickert, R. C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352.
31. Melamed, D., and D. Nemazee. 1997. Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc. Natl. Acad. Sci. USA 94:9267.
32. Melamed, D., J. A. Kench, K. Grabstein, A. Rolink, and D. Nemazee. 1997. A functional B cell receptor transgene allows efficient IL-7-independent maturation of B cell precursors, J. Immunol. 159:1233.
33. Winkler, T. H., F. Melchers, and A. G. Rolink. 1995. Interleukin-3 and interleukin-7 are alternative growth factors for the same B-cell precursors in the mouse. Blood 85:2045.
34. Hardy, R. R., C. E. Carmack, S. A. Shinton, J. D. Kemp, and K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med, 173:1213.
35. Tiegs, S. L., D. M. Russell, and D. Nemazee. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1009.
36. Shivticl, S., N. Leider, O. Sadch, Z. Kraiem, and D. Melamed. 2002. Impaired light chain allelic exclusion and lack of positive selection in immature B cells expressing incompetent receptor deficient of CD19. J. Immunol. 168:5596.
37. Iritani, B. M., and R. N. Eisenman. 1999. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl. Acad. Sci. USA 96:13180.
38. Iritani, B. M., J. Delrow, C. Grandori, I. Gomez, M. Klacking, L. S. Carlos, and R. N. Eisenman. 2002. Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1. EMBO J. 21:4820.
39. Douglas, N. C., H. Jacobs, A. L. Bothwell, and A. C. Hayday. 2001. Defining the specific physiological requirements for c-Myc in T cell development. Nat. Immunol. 2:307.
40. Zaldumbide, A., F. Carlotti, P. Pognonec, and K. E. Boulukos. 2002. The role of the Ets2 transcription factor in the proliferation, maturation, and survival of mouse thymocytes. J. Immunol. 169:4873.
41. Monroe, J. G. 1996. Tolerance sensitivity of immature-stage B cells. J. Immunol. 156:2657.
42. Nossal, G. J. 1994. Negative selection of lymphocytes. Cell 76:229.
43. Schuhmacher M., F. Kohlhuber, M. Holzel, C. Kaiser, H. Burtscher, M. Jarsch, G. W. Bornkamm, G. Laux, A. Polack, U. H. Weidle, and D. Eick. 2001. The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res. 29:397.
44. Monroe, R. J., K. J. Seidl, F. Gaertner, S. Han, F. Chen, J. Sekiguchi, J. Wang, R. Ferrini, L. Davidson, G. Kelsoe, and F. W. Alt. 1999. RAG2:GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues. Immunity 11:201.
45. Yu, W., H. Nagaoka, M. Jankovic, Z. Misulovin, H. Suh, A. Rolink, F. Melchers, E. Meffre, and M. C. Nussenzweig. 1999. Continued RAG expression in late stages of B cell development and no apparent re-induction after immunization. Nature 400:682.
46. Fuller, K., and U. Storb. 1997. Identification and characterization of the murine Ragl promoter. Mol. Immunol. 34:939.
47. Li, Z., D. I. Dordai, J. Lee, and S. Dcsiderio. 1996. A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle. Immunity 5:575.
48. Ma, A., P. Fisher, R. Dildrop, E. Oltz, G. Rathbun, P. Achacoso, A. Stall, and F. W. Alt. 1992. Surface IgM mediatcd regulation of RAG gene expression in E μ-N-myc B cell lines. EMBO J. 11:2727.
49. Kuhn-Hallek, I., D. R. Sage, L. Stein, H. Groelle, and J. D. Fingeroth. 1995. Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells. Blood 85:1289.
50. Lens, D., E. Matutes, N. Farahat, R. Morilla, and D. Catovsky. 1994. Differential expression of c-myc protein in B and T lymphocytes. Leukemia 8:2102.
51. de Alboran, I. M., R. C. O'Hagan, F. Gartner, B. Malynn, L. Davidson, R. Rickert, K. Rajewsky, R. A. DePinho, and F. W. Alt. 2001. Analysis of c-Myc function in normal cells via conditional gene-targeted mutation. Immunity 14:45.
52. Tsubata, T. 2001. Molecular mechanisms for apoptosis induced by signaling through the B cell antigen receptor. Int. Rev. Immunol 20:791.